153 related articles for article (PubMed ID: 35882941)
1. Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis.
Shu X; Zhou Q; Sun X; Flesaker M; Guo X; Long J; Robson ME; Shu XO; Zheng W; Bernstein JL
Br J Cancer; 2022 Nov; 127(8):1507-1514. PubMed ID: 35882941
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes.
Chen F; Wen W; Long J; Shu X; Yang Y; Shu XO; Zheng W
Int J Cancer; 2022 Aug; 151(3):372-380. PubMed ID: 35403707
[TBL] [Abstract][Full Text] [Related]
3. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.
Jung AY; Ahearn TU; Behrens S; Middha P; Bolla MK; Wang Q; Arndt V; Aronson KJ; Augustinsson A; Beane Freeman LE; Becher H; Brenner H; Canzian F; Carey LA; ; Czene K; Eliassen AH; Eriksson M; Evans DG; Figueroa JD; Fritschi L; Gabrielson M; Giles GG; Guénel P; Hadjisavvas A; Haiman CA; Håkansson N; Hall P; Hamann U; Hoppe R; Hopper JL; Howell A; Hunter DJ; Hüsing A; Kaaks R; Kosma VM; Koutros S; Kraft P; Lacey JV; Le Marchand L; Lissowska J; Loizidou MA; Mannermaa A; Maurer T; Murphy RA; Olshan AF; Olsson H; Patel AV; Perou CM; Rennert G; Shibli R; Shu XO; Southey MC; Stone J; Tamimi RM; Teras LR; Troester MA; Truong T; Vachon CM; Wang SS; Wolk A; Wu AH; Yang XR; Zheng W; Dunning AM; Pharoah PDP; Easton DF; Milne RL; Chatterjee N; Schmidt MK; García-Closas M; Chang-Claude J
J Natl Cancer Inst; 2022 Dec; 114(12):1706-1719. PubMed ID: 35723569
[TBL] [Abstract][Full Text] [Related]
4. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study.
Tan H; Wang S; Huang F; Tong Z
Front Endocrinol (Lausanne); 2023; 14():1138149. PubMed ID: 37288296
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study.
Zhou H; Cai Z; Yang Q; Yang X; Chen J; Huang T
PLoS One; 2023; 18(11):e0293230. PubMed ID: 37910571
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
[TBL] [Abstract][Full Text] [Related]
7. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.
Gaudet MM; Gierach GL; Carter BD; Luo J; Milne RL; Weiderpass E; Giles GG; Tamimi RM; Eliassen AH; Rosner B; Wolk A; Adami HO; Margolis KL; Gapstur SM; Garcia-Closas M; Brinton LA
Cancer Res; 2018 Oct; 78(20):6011-6021. PubMed ID: 30185547
[TBL] [Abstract][Full Text] [Related]
8. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
[TBL] [Abstract][Full Text] [Related]
10. The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study.
Dong H; Kong X; Wang X; Liu Q; Fang Y; Wang J
Nutrients; 2023 May; 15(11):. PubMed ID: 37299548
[TBL] [Abstract][Full Text] [Related]
11. Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study.
Tang SN; Zuber V; Tsilidis KK
BMC Med; 2022 Nov; 20(1):457. PubMed ID: 36424572
[TBL] [Abstract][Full Text] [Related]
12. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
13. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk.
Shu X; Bao J; Wu L; Long J; Shu XO; Guo X; Yang Y; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Castelao JE; Dörk T; Gago-Dominguez M; García-Closas M; Giles GG; Lophatananon A; Muir K; Olsson H; Rennert G; Saloustros E; Scott RJ; Southey MC; Pharoah PDP; Milne RL; Kraft P; Simard J; Easton DF; Zheng W
Int J Cancer; 2020 Apr; 146(8):2130-2138. PubMed ID: 31265136
[TBL] [Abstract][Full Text] [Related]
15. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
16. Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study.
Lu Y; Tang H; Huang P; Wang J; Deng P; Li Y; Zheng J; Weng L
Int J Epidemiol; 2022 Aug; 51(4):1204-1218. PubMed ID: 35218345
[TBL] [Abstract][Full Text] [Related]
17. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study.
Chitkara A; Mesa-Eguiagaray I; Wild SH; Hall PS; Cameron DA; Sims AH; Figueroa JD
Breast Cancer Res Treat; 2022 Nov; 196(2):379-387. PubMed ID: 36116093
[TBL] [Abstract][Full Text] [Related]
18. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
Front Immunol; 2022; 13():956005. PubMed ID: 36159838
[TBL] [Abstract][Full Text] [Related]
19. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E
Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
